SRx Health (SRXH) Fundamental Analysis: Revenue, Earnings & Valuation

8.33 / 10

Outperform

Fundamentals score 8.33/10, rated Outperform. Key strengths: PB‑ROE, Cash‑MV, Asset‑MV, profit and cash‑flow growth. Weak spots: Cash‑UP and Revenue‑MV relative to market value. Overall highly favorable.

Analysis Checks(8/10)

Revenue-MV

Value-0.11

Score0/3

Weight-13.91%

1M Return-6.46%

Net cash flow from operating activities per share (YoY growth rate %)

Value61.19

Score3/3

Weight18.39%

1M Return5.35%

PB-ROE

Value-1.05

Score2/3

Weight2.51%

1M Return0.81%

Basic earnings per share (YoY growth rate %)

Value-9.23

Score2/3

Weight4.89%

1M Return1.70%

Total profit (YoY growth rate %)

Value122.81

Score2/3

Weight5.72%

1M Return1.87%

Net cash flow from operating activities (YoY growth rate %)

Value-450.95

Score3/3

Weight18.75%

1M Return5.57%

Cash-UP

Value-0.15

Score1/3

Weight1.93%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value-9.23

Score2/3

Weight3.58%

1M Return1.25%

Asset-MV

Value-0.55

Score3/3

Weight34.12%

1M Return9.13%

Cash-MV

Value4.85

Score3/3

Weight24.02%

1M Return6.61%

Is SRXH fundamentally strong?

SRXH scores 8.33/10 on fundamentals and holds a Discounted valuation at present. Backed by its -438.26% ROE, -531.39% net margin, -0.85 P/E ratio, 11.99 P/B ratio, and -250.00% earnings growth, these metrics solidify its Outperform investment rating.